drugset

drugset / Trial / NCT00233103

Treatment of Post-Traumatic Brain Injury (TBI) Depression

NCT00233103 ↗

Phase 2 Completed 52 enrolled Icahn School of Medicine at Mount Sinai U.S. Department of Education · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized clinical trial of sertraline vs. placebo for post-TBI depression

Timeline

Start: 2003-06
Primary completion: 2008-09
Completion: 2008-09

Publications

Ashman TA, Cantor JB, Gordon WA, Spielman L, Flanagan S, Ginsberg A, Engmann C, Egan M, Ambrose F, Greenwald B. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Arch Phys Med Rehabil. 2009 May;90(5):733-40. doi: 10.1016/j.apmr.2008.11.005.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sertraline	Small molecule	200 mg	Oral

Indications